おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
NUVISAN GmbH
company
About
NUVISAN GmbH provides product development and support services to the pharmaceutical, biotechnology, and medical device industries.
- Neu-ulm,Bayern,Germany
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $9.60M
- Industries
- Medical,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 1979
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Also Known As
- AAIPharma Deutschland GmbH & Co. KG
Nuvisan Pharma Services is a global provider of product development andsupport services to the pharmaceutical, biotechnology and medical deviceindustries. We deliver services ranging from a single test to fully integrateddrug development programs.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$9.60M
NUVISAN GmbH has raised a total of
$9.60M
in funding over 2 rounds. Their latest funding was raised on
Sep 20, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 20, 2022 | Grant | $9.60M | 1 |
Bill & Melinda Gates Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
NUVISAN GmbH is funded by 1 investors.
Bill & Melinda Gates Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Bill & Melinda Gates Foundation
|
Yes | Grant |
Employee Profiles
Number of Employee Profiles
3
NUVISAN GmbH has 3 current employee profiles, including
Executive Dietrich Bruchmann
Acquisition
NUVISAN GmbH has acquired 1 organizations. Their most recent acquisition was Essex Pharma Development on Jun 1, 2011. They acquired Essex Pharma Development for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Jun 1, 2011
|
Analytics | acquisition | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
